Nürnberger Beteiligungs — Steady progress in unfavourable environment

Nurnberger Beteiligungs (DB: NBG6)

Last close As at 15/06/2024


−0.50 (−0.63%)

Market capitalisation


More on this equity

Research: Financials

Nürnberger Beteiligungs — Steady progress in unfavourable environment

Nürnberger Beteiligungs (NBG) was able to moderately grow its gross premiums booked on the back of a solid 10% y-o-y increase in new premiums to €266m in H119. Meanwhile, the low interest rate environment dampens NBG’s investment income, with the recent central bank rate decisions suggesting this will continue for now. We note that NBG’s relatively high exposure to unit-linked and disability products somewhat limits the impact of accommodative monetary policy. A cap on fees earned on life insurance contracts is still being discussed in Germany. If introduced, it is likely to constrain new life insurance business.

Milosz Papst

Written by

Milosz Papst

Director, Financials


Nürnberger Beteiligungs

Steady progress in unfavourable environment


Scale research report - Update

18 September 2019



Market cap


Share price graph

Share details




Deutsche Börse Scale

Shares in issue


Liquid resources at end-June 2019


Business description

Nürnberger Beteiligungs is the parent company of a group of insurers and financial service companies. It is one of Germany’s oldest insurers, operating since 1884. It offers life, health and property and casualty insurance, with strongest demand for unit-linked life, disability and pension insurance and standard pension insurance.


Very strong finances and conservative reporting.

Well-established brand name and solid historical performance.

Stable annual dividend payments.


Low interest rate environment.

Regulatory uncertainty.

Highly competitive industry.


Milosz Papst

+44 (0)20 3077 5700

Nürnberger Beteiligungs (NBG) was able to moderately grow its gross premiums booked on the back of a solid 10% y-o-y increase in new premiums to €266m in H119. Meanwhile, the low interest rate environment dampens NBG’s investment income, with the recent central bank rate decisions suggesting this will continue for now. We note that NBG’s relatively high exposure to unit-linked and disability products somewhat limits the impact of accommodative monetary policy. A cap on fees earned on life insurance contracts is still being discussed in Germany. If introduced, it is likely to constrain new life insurance business.

H119 net income slightly down

NBG’s pre-tax profit was broadly stable y-o-y at €39.0m in H119, assisted by lower additions to Zinszusatzreserve (ZZR) (€39.3m vs €140.6m in H118) and c 0.9% growth in gross premiums to €1.77bn. On the other hand, as expected by management, NBG generated lower disposal gains as part of its investment income related to standard insurance contracts (€115.5m vs €146.4m in H118). Moreover, NBG’s claims expenses rose 5.3% to €1.3m in H119, while operating expenses increased 10.7% y-o-y to €301.7m. A higher effective tax rate led to net income ex-minorities of €21.3m (down 0.9% y-o-y) or €22.1m (down 6.1% y-o-y) post-minorities.

FY19 guidance reiterated

NBG confirmed its earlier net income guidance for FY19 at €55m, which implies a c 10% y-o-y decline. The company expects a slight increase in new premiums in the life insurance business, with gross premiums booked at a level similar to FY18. In property and casualty (P&C), it anticipates a significant rise in new business, driven by consistent growth in property, personal liability, accident and vehicle insurance. This should result in visibly higher gross premiums booked. At the same time, it expects a solid increase in gross premiums in the health insurance segment. The above should be assisted by broader market growth, as the German Insurance Association (GDV) expects gross premiums to increase by 3% in 2019.

Valuation: Sustained dividend payout

Based on the company’s net income guidance for FY19, NBG’s shares are trading at a c 36% premium to its peer group on a P/E ratio. Based on the recently paid dividend of €3.0 per share (which has remained stable since 2013), the shares offer a yield of c 4.3%.

Historical financials




































Source: NBG accounts

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

H119 results: Further growth in gross premiums

NBG reported 0.9% y-o-y growth in gross premiums booked to €1.77bn in H119, assisted by all three major business lines (life, P&C and health insurance). This is slightly ahead of earlier management guidance for FY19 of stable gross premiums at group level and specifically in life insurance (at the time, the company expected gross premiums in health and P&C insurance to increase in FY19). NBG’s new premiums improved by a healthy c 10% y-o-y to €266m (after growing 7.8% y-o-y in FY18), which was particularly driven by life insurance (up 9.2% y-o-y or by €15.9m) and P&C (up 11.9% y-o-y or €7.5m). Health insurance recorded a similar increase in new premiums (+9.3% y-o-y), but due to its lower share in group business its contribution was below the other two segments. Although net commission income (mostly generated by the bank services segment) remained stable y-o-y at c €25m, NBG achieved a much higher gross investment income of €553.7m in H119 compared with €424.5m in H118. Consequently, the company’s total revenue rose by 6.6% y-o-y to €2,347m in H119.

That said, net investment income related to the standard insurance business was up only marginally by 1% y-o-y to €373.3m in H119 on the back of a 10% y-o-y increase in current income to €282.0m. However, this was largely offset by the decline in realised disposal gains (down 21% y-o-y to €115.5m). The company had anticipated the latter and factored it into FY19 guidance.

NBG’s life insurance business (which makes up c 67% of the insurer’s gross premiums) continues to be assisted by changes in the calculation of ZZR (see our previous update note for a detailed discussion). As a result, the ZZR increase in H119 stood at €39.3m (vs €140.6m in H118). As capital markets rebounded in the first half of the year, the increase in technical reserves associated with unit-linked products had a negative impact of €935.3m (as distributions are not at a fixed pre-set level, but dependent on the performance of the underlying investment portfolio in the insurance product). However, the latter is by definition accompanied by an opposite move in unrealised profits/losses from unit-linked insurance investments booked by NBG (which was €816.2m in H119 compared with a loss of €181.3m in H118). On top of this, net investment income related to unit-linked products stood at €132.7m (vs €5.1m in H118). Overall, the impact on the P&L of the change in technical reserves stood at a loss of €1,147.9m in H119 vs a €172.9m loss in H118.

Exhibit 1: H119 results highlights

€m unless otherwise stated



Change y-o-y

Gross premiums booked




Premiums earned




Net result on premium refunds




Investment income




Unrealised profits/losses from unit-linked insurance investments




Other net technical income/(expense)




Claims expenses




Change in other technical provisions




Operating expenses




Change in equalisation and other reserves




Other net (non-technical) income/(expense)




Goodwill amortization




Extraordinary result




Pre-tax profit




Income and other taxes




effective tax rate




Net income (incl. minorities)








Net income (ex-minorities)




Source: NBG accounts

NBG’s claim expenses amounted to €1.2bn in H119 and were up 5.3% y-o-y, driven by all segments, with life insurance up 4.6% y-o-y, P&C +3.1% and health +29.0%. At the same time, operating expenses rose by as much as 10.7% y-o-y to €301.7m, which we suspect is associated with the acquisition costs of new insurance business. As a result, net income reached €22.1m and was down 6.1% y-o-y. This compares with management guidance for FY19 of a c 10% y-o-y decline in net income. On a last 12-months (LTM) basis, NBG’s return on equity including minorities reached 7.4%, broadly in line with FY18.

Segment analysis

Gross premiums in life insurance went up slightly by 0.5% y-o-y to €1.2bn, which is quite a decent result given management’s earlier expectations of flat gross premiums in FY19. As mentioned above, NBG’s new premiums in the life insurance business improved by 9.2% y-o-y to €189.5m in H119, with the single-premium business growing at 8.6% y-o-y, while business based on regular premium payments improved by 10.0% y-o-y. The key product groups driving this healthy result were unit-linked life and pension insurance, traditional pension insurance, as well as disability insurance. The segment result increased slightly to €18.2m in H119 from €17.7m in H118.

In this segment, NBG plans to increase its emphasis on income protection products. Moreover, it recently created a subsidiary to develop new digital solutions in personal insurance to address the needs of customers who are interested in obtaining insurance cover using online channels. The first result of these activities is a new digital basic capability insurance product, which represents a leaner version of NBG’s standard basic capability insurance. It can be expanded to include additional modules (Mobility, Office and Psyche). Although the share of direct distribution (including online purchases) remains a relatively small proportion of the overall sale of life insurance products in Germany for now (at 2.2% in 2018 according to GDV and unchanged from the prior year), we acknowledge NBG’s efforts to address this promising distribution channel.

In the P&C business, new premiums went up 11.9% y-o-y to €70.6m in H119, with €42.6m in vehicle insurance, €23.6m from property, personal liability and accident insurance, as well as €4.4m from legal protection insurance. This translated into an 1.2% y-o-y increase in gross premiums to €461.6m, as some business disposal in legal protection insurance was more than offset by growth in other products. In the period, NBG booked premiums earned of €314.8m, which is 8.3% ahead of last year. As claims expenses were up more moderately by 3.1% y-o-y to €186.0m (while operating expenses increased by 9.7% y-o-y to €106.5m), NBG was able to achieve a better combined ratio of 93.2% in H119 compared with 95.8% last year. We note that last year claims were particularly affected by natural disasters, including in particular Storm Friederike. Consequently, the segment result in P&C reached €7.5m in H119 vs €7.6m in H118.

Gross premiums in the health insurance segment increased by 3.9% to €113.8m in H119, with new premiums up by 9.3% y-o-y to €5.9m in H119. This was particularly supported by full insurance products (similar to FY18), while premiums in supplementary insurance were below last year. Segment results reached €2.5m compared with €2.3m a year ago. It is worth noting that since January 2019, NBG has been co-operating with TeleClinic, allowing the company’s customers to seek medical advice and obtain prescriptions through a mobile application, PC or telephone from anywhere and also outside standard opening hours of a medical facility.

Commission income in banking services remained broadly unchanged y-o-y at €20.1m (€20.0m in H118), while the segment result was up to €3.3m from €2.1m in H118.


As there are no Refinitiv consensus estimates for NBG, our P/E calculations for 2019 are based on management’s FY19 net profit guidance of €55m. We feel it is an appropriate measure as management expectations appear relatively conservative, as exhibited by the FY18 earnings beat. Based on these figures, the company is trading at a c 36% premium to the peer group. NBG pays an annual dividend of €3 per share, implying a 4.3% yield, which is a c 14% premium to peers.

Exhibit 2: Peer group comparison

Market cap (lcy m)

Share price (lcy)

P/E (x)

Dividend yield (%)





UNIQA Insurance Group







Helvetia Holding

6,822 CHF






Baloise Holding














Swiss Life Holding

16,495 CHF






NN Group







CNP Assurances




























Peer group average





Nürnberger Beteiligungs












Source: Refinitiv consensus at 16 September 2019. Note: *Calculated based on management guidance (no consensus available). **Yield calculated based on dividend payment from 2018 earnings.

General disclaimer and copyright

Any Information, data, analysis and opinions contained in this report do not constitute investment advice by Deutsche Börse AG or the Frankfurter Wertpapierbörse. Any investment decision should be solely based on a securities offering document or another document containing all information required to make such an investment decision, including risk factors. This report has been commissioned by Deutsche Börse AG and prepared and issued by Edison for publication globally.

Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.


Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt


London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Nurnberger Beteiligungs

View All

Latest from the Financials sector

View All Financials content

Research: Industrials

Cohort — Order cover strengthens further

Cohort’s AGM statement indicates the current year has progressed well, with order cover of sales for the year rising to 76% following recent September orders compared to 60% at the same point of FY19. The order backlog at 31 August 2019 increased by over 10% since the year end to a record £210.9m (FY19 £190.9m) and the pipeline of potential business remains healthy. We maintain our earnings estimates, which means the shares are trading on an FY21e P/E of 12.6x, a significant and unwarranted discount to UK defence peers.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free